Page last updated: 2024-08-26

sr141716 and Constipation

sr141716 has been researched along with Constipation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fabisiak, A; Fabisiak, N; Fichna, J; Storr, M; Włodarczyk, M	1

Reviews

1 review(s) available for sr141716 and Constipation

Article	Year
Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis. Journal of gastrointestinal and liver diseases : JGLD, 2019, Dec-09, Volume: 28, Issue:4 Topics: Amides; Cannabinoid Receptor Antagonists; Constipation; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Irritable Bowel Syndrome; Mental Disorders; Pyridines; Rimonabant	2019

Article

Year

Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis.

Journal of gastrointestinal and liver diseases : JGLD, 2019, Dec-09, Volume: 28, Issue:4

Topics: Amides; Cannabinoid Receptor Antagonists; Constipation; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Irritable Bowel Syndrome; Mental Disorders; Pyridines; Rimonabant

2019